| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/12/2008 | CA2679841A1 Variant activin receptor polypeptides and uses thereof |
| 09/12/2008 | CA2679831A1 Treating stroke and other diseases without inhibiting n-type calcium channels |
| 09/12/2008 | CA2679743A1 Methods and compositions involving polymeric immunoglobulin fusion proteins |
| 09/12/2008 | CA2679545A1 Osteopontin for the prediction and treatment of cardiovascular diseases |
| 09/12/2008 | CA2679410A1 Novel method and compositions |
| 09/12/2008 | CA2679321A1 Diagnosis of collagen ix destruction |
| 09/12/2008 | CA2679045A1 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them |
| 09/12/2008 | CA2678555A1 Amelioration of cellular stress response |
| 09/12/2008 | CA2678465A1 Method of determining nt-probnp |
| 09/12/2008 | CA2668018A1 Immunogenic and therapeutic compositions for streptococcus pyogenes |
| 09/11/2008 | US20080221309 MN Gene and Protein |
| 09/11/2008 | US20080221305 Polynucleotides encoding novel adiponectin receptor variants |
| 09/11/2008 | US20080221304 Hexapeptide of given formula; binds with opioid receptor and exhibits agonist and antagonist activity; anxiolytics, diuretics, and anti-cancer agents |
| 09/11/2008 | US20080221240 Functionalization of nanoscale articles including nanotubes and fullerenes |
| 09/11/2008 | US20080221215 Antiviral inhibition of capsid proteins |
| 09/11/2008 | US20080221193 3-amino chromane derivatives |
| 09/11/2008 | US20080221050 Genetic polymorphisms linked to optic neuropathy including glaucoma and Leber's disease; point mutations; enothelins; angiotensins; gene expression inhibition |
| 09/11/2008 | US20080221041 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 09/11/2008 | US20080221040 Compositions and Methods for the Control of Mammary Cell Number |
| 09/11/2008 | US20080221035 For killing Group B streptococci; endopeptidase and muramidase domains |
| 09/11/2008 | US20080221034 Canine specific growth hormone releasing hormone |
| 09/11/2008 | US20080221032 Proteinaceous construct; an activated factor VII molecule anda 1-4 polysialic acid; controlling bleeding in a mammal during surgery or trauma |
| 09/11/2008 | US20080221028 Compositions and Methods for Treating Atherosclerosis |
| 09/11/2008 | US20080221026 Fermentation; producing NAP in a suitable host, integrating a sequence encoding NAP into the genome of the host; a recovery process of separating NAP from cells and cellular debris; purification |
| 09/11/2008 | US20080221024 ShK toxin attached to an atom, molecule, group, residue, compound, moiety that has an anionic charge; multiple sclerosis, type-1 diabetes mellitus, rheumatoid arthritis and psoriasis |
| 09/11/2008 | US20080221021 Novel Corticotropin-Releasing Factor Receptor 1 (Crfr1) Agonist |
| 09/11/2008 | US20080221015 Isolated peptide; a variant, derivative or structural equivalent of a cupredoxin binding to an ephrin receptor; anticarcinogen |
| 09/11/2008 | US20080221012 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types |
| 09/11/2008 | US20080220987 Methods, Kits and Compositions Pertaining to Combination Oligomers and Libraries for Their Preparation |
| 09/11/2008 | US20080220981 Chimeric binding peptide library screening method |
| 09/11/2008 | US20080220540 Method for purifying cancer-specific proliferating cell nuclear antigen |
| 09/11/2008 | US20080220527 Modular transfection systems |
| 09/11/2008 | US20080220503 Screening method for genes of brewing yeast |
| 09/11/2008 | US20080220502 Using vector comprising mutator genes as tool for generation of genomic variance; enhancing rate of genic change |
| 09/11/2008 | US20080220497 Modulation of protein functionalities |
| 09/11/2008 | US20080220484 Reducing substituted alkanones such as 3-methylamino-1-(2-thienyl)-propan-1-one; biosynthesis; expression cassettes; host cells; for production of duloxetine |
| 09/11/2008 | US20080220477 pdCpA is bound to an amino acid such as phenylalanine, tryptophan or tyrosine or derivative allowed to react with 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indecene-3-propionic acid label to form a labeled amino acid-pdCpA conjugate, which is then bound to tRNA(CA-); functional protein synthesis |
| 09/11/2008 | US20080220475 mTOR LIGANDS AND POLYNUCLEOTIDES ENCODING mTOR LIGANDS |
| 09/11/2008 | US20080220456 Luminescence resonance energy transfer (lret) assays for clostridial toxin activity |
| 09/11/2008 | US20080220455 p53-DEPENDENT APOPTOSIS-INDUCING PROTEIN AND METHOD OF SCREENING FOR APOPTOSIS REGULATOR |
| 09/11/2008 | US20080220451 T1r2 binding assays |
| 09/11/2008 | US20080220446 Method for Detecting and/or Removing Protein and/or Peptide Comprising a Cross-Beta Structure From an Aqueous Solution Comprising a Protein |
| 09/11/2008 | US20080220419 Oligonucleotide primers/probes; cytochrome p450 monooxygenase enzyme system; expression vectors; kits |
| 09/11/2008 | US20080220410 Method for replicating the hepatitis c virus |
| 09/11/2008 | US20080220095 Red blood cells loaded with s-nitrosothiol and uses therefor |
| 09/11/2008 | US20080220056 Treatment for liver disease |
| 09/11/2008 | US20080220014 Recombinant viral-based malaria vaccines |
| 09/11/2008 | US20080220011 Flagellin/tumor antigen fusion for use in induction of immune response to cancer antigen; tissue targeted therapy; antitumor agents |
| 09/11/2008 | US20080220009 Composition comprising hepadnavirus core antigen for use in preparing vaccines against hepatitis infection |
| 09/11/2008 | US20080220007 Ehrlichia canis genes and vaccines |
| 09/11/2008 | US20080220004 Administering fusion proteins, immunoglobulins, and multimeric proteins; pharmacokinetics; age-related macular degeneration and diabetic retinopathy |
| 09/11/2008 | US20080220002 Modified transferin-antibody fusion proteins |
| 09/11/2008 | US20080219999 Immunoadhesin for the prevention of rhinovirus infection |
| 09/11/2008 | US20080219997 Her-2 binding antagonists |
| 09/11/2008 | US20080219994 Modified bouganin proteins, cytotoxins and methods and uses thereof |
| 09/11/2008 | US20080219993 RalGDS related (RGR) protein specific immunoglobulin for treatment and prevention of cell proliferative disorders |
| 09/11/2008 | US20080219992 Pancreatic protein for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219991 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219990 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219989 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219988 Polypeptide comprising major histocompatibility complex epitopes for targeting and destroying tumor cells |
| 09/11/2008 | US20080219986 Neisserial protein for use in diagnosis, prevention and treatment of microorganismal infection |
| 09/11/2008 | US20080219984 Nucleotide sequences coding myelin-associated glycoprotein receptor for use in identifying modulators for treatment of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease |
| 09/11/2008 | US20080219983 Antihemophilic factor specific peptides for use as therapeutic tools in treatment of blood disorders |
| 09/11/2008 | US20080219982 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219981 Solid cancer antigenic polypeptide for use in designing and identifying modulators for prevention and treatment of tumorous masses |
| 09/11/2008 | US20080219968 Son of sevenless homolog 1 (SOS1) suppressive agent for prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219967 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases |
| 09/11/2008 | US20080219954 Viral vector comprising adenovirus capsid gene sequences for use as tool for delivery and expression of heterologous gene sequences in cells |
| 09/11/2008 | US20080219952 culturing a human interferon producing cells in a serum-free medium, comprising hydroxyethyl piperazinyl ethanesulfonic acid(HEPES), proline sodium chloride and phenol red; drugs used for treating multiple sclerosis, viral diseases or cancer |
| 09/11/2008 | US20080219950 Derivatives of growth hormone and related proteins |
| 09/11/2008 | US20080219947 Single chain trimers and uses therefor |
| 09/11/2008 | US20080219925 Delta opioid receptor protein |
| 09/11/2008 | US20080219924 Imaging, diagnosis and treatment of disease |
| 09/11/2008 | DE102007011241A1 Isoliertes Photoprotein mtClytinDecay, sowie dessen Verwendung The isolated photoprotein mtClytinDecay, and its use |
| 09/11/2008 | DE102006050091A1 Verfahren zur selektiven Lokalisierung von Wirkstoffen an und in Mitochondrien und entsprechende Wirkstoffe Process for the selective localization of active ingredients to and in mitochondria and corresponding active ingredients |
| 09/10/2008 | EP1967590A2 Lentiviral packaging constructs |
| 09/10/2008 | EP1967589A2 An oleosin 5' regulatory region for the modification of plant seed lipid composition |
| 09/10/2008 | EP1967587A1 APO-3 Ligand |
| 09/10/2008 | EP1967586A1 84P2A9: A prostate and testis specific protein highly expressed in prostate cancer |
| 09/10/2008 | EP1967526A1 Inhibitor of TGF-ß activation reaction |
| 09/10/2008 | EP1967525A2 A method for regulating immune function in primates using the foxp3 protein |
| 09/10/2008 | EP1967520A2 Production of polyketides and other natural products |
| 09/10/2008 | EP1967208A1 THERAPEUTIC AGENT FOR SKIN OR SKIN REPAIR-PROMOTING AGENT COMPRISING GHRELIN, DERIVATIVE THEREOF OR SUBSTANCE CAPABLE OF ACTING ON GHS-R1a AS ACTIVE INGREDIENT |
| 09/10/2008 | EP1967206A2 Anti-IgE vaccines |
| 09/10/2008 | EP1967205A2 Anti-IgE vaccines |
| 09/10/2008 | EP1967201A1 Therapeutic agent for skin or skin repair-promoting agent comprising des-acylghrelin or derivative thereof as active ingredient |
| 09/10/2008 | EP1966388A2 Targeting vector-phospholipid conjugates |
| 09/10/2008 | EP1966384A2 Viral vectors |
| 09/10/2008 | EP1966380A1 Method for preventing and/or treating articles or media contaminated with bacteria of the legionella genus |
| 09/10/2008 | EP1966244A1 Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130 |
| 09/10/2008 | EP1966240A1 Peptides useful as cell-penetrating peptides |
| 09/10/2008 | EP1966239A1 Octanoate-reduced human albumin |
| 09/10/2008 | EP1966238A1 Interleukin-12p40 variants with improved stability |
| 09/10/2008 | EP1966237A2 Erythropoietin polypeptides and uses thereof |
| 09/10/2008 | EP1966236A1 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 09/10/2008 | EP1966235A2 Antimicrobial cathelicidin peptides |
| 09/10/2008 | EP1966232A1 Purification of proteins using preparative reverse phase chromatography (rpc) |
| 09/10/2008 | EP1965829A1 Alternative oxidase and uses thereof |
| 09/10/2008 | EP1965811A2 Device and method for cell grafting |